Global Premenstrual Syndrome Treatment Market Research Report 2024(Status and Outlook)
Report Overview:
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
The Global Premenstrual Syndrome Treatment Market Size was estimated at USD 1362.84 million in 2023 and is projected to reach USD 1665.59 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Premenstrual Syndrome Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Premenstrual Syndrome Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Premenstrual Syndrome Treatment market in any manner.
Global Premenstrual Syndrome Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
AstraZeneca
BASF Corporation
Bayer
Eli Lilly And Company
GlaxoSmithKline
Pfizer
Shionogi
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
Allergan plc
Mylan N.V.
Market Segmentation (by Type)
Medication
Dietary Treatment
Emotional Treatment
Hormone Therapy
Others
Market Segmentation (by Application)
Younger than 20 Years
20-40 Years Old Adults
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Premenstrual Syndrome Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
The Global Premenstrual Syndrome Treatment Market Size was estimated at USD 1362.84 million in 2023 and is projected to reach USD 1665.59 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.
This report provides a deep insight into the global Premenstrual Syndrome Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Premenstrual Syndrome Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Premenstrual Syndrome Treatment market in any manner.
Global Premenstrual Syndrome Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
AstraZeneca
BASF Corporation
Bayer
Eli Lilly And Company
GlaxoSmithKline
Pfizer
Shionogi
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
Allergan plc
Mylan N.V.
Market Segmentation (by Type)
Medication
Dietary Treatment
Emotional Treatment
Hormone Therapy
Others
Market Segmentation (by Application)
Younger than 20 Years
20-40 Years Old Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Premenstrual Syndrome Treatment Market
- Overview of the regional outlook of the Premenstrual Syndrome Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Premenstrual Syndrome Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Premenstrual Syndrome Treatment
1.2 Key Market Segments
1.2.1 Premenstrual Syndrome Treatment Segment by Type
1.2.2 Premenstrual Syndrome Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PREMENSTRUAL SYNDROME TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Premenstrual Syndrome Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Premenstrual Syndrome Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PREMENSTRUAL SYNDROME TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Premenstrual Syndrome Treatment Sales by Manufacturers (2019-2024)
3.2 Global Premenstrual Syndrome Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Premenstrual Syndrome Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Premenstrual Syndrome Treatment Sales Sites, Area Served, Product Type
3.6 Premenstrual Syndrome Treatment Market Competitive Situation and Trends
3.6.1 Premenstrual Syndrome Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Premenstrual Syndrome Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PREMENSTRUAL SYNDROME TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Premenstrual Syndrome Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PREMENSTRUAL SYNDROME TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Premenstrual Syndrome Treatment Sales Market Share by Type (2019-2024)
6.3 Global Premenstrual Syndrome Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Premenstrual Syndrome Treatment Price by Type (2019-2024)
7 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Premenstrual Syndrome Treatment Market Sales by Application (2019-2024)
7.3 Global Premenstrual Syndrome Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
8 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Premenstrual Syndrome Treatment Sales by Region
8.1.1 Global Premenstrual Syndrome Treatment Sales by Region
8.1.2 Global Premenstrual Syndrome Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Premenstrual Syndrome Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Premenstrual Syndrome Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Premenstrual Syndrome Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Premenstrual Syndrome Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Premenstrual Syndrome Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Premenstrual Syndrome Treatment Basic Information
9.1.2 AbbVie Premenstrual Syndrome Treatment Product Overview
9.1.3 AbbVie Premenstrual Syndrome Treatment Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Premenstrual Syndrome Treatment SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Premenstrual Syndrome Treatment Basic Information
9.2.2 AstraZeneca Premenstrual Syndrome Treatment Product Overview
9.2.3 AstraZeneca Premenstrual Syndrome Treatment Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Premenstrual Syndrome Treatment SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 BASF Corporation
9.3.1 BASF Corporation Premenstrual Syndrome Treatment Basic Information
9.3.2 BASF Corporation Premenstrual Syndrome Treatment Product Overview
9.3.3 BASF Corporation Premenstrual Syndrome Treatment Product Market Performance
9.3.4 BASF Corporation Premenstrual Syndrome Treatment SWOT Analysis
9.3.5 BASF Corporation Business Overview
9.3.6 BASF Corporation Recent Developments
9.4 Bayer
9.4.1 Bayer Premenstrual Syndrome Treatment Basic Information
9.4.2 Bayer Premenstrual Syndrome Treatment Product Overview
9.4.3 Bayer Premenstrual Syndrome Treatment Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Recent Developments
9.5 Eli Lilly And Company
9.5.1 Eli Lilly And Company Premenstrual Syndrome Treatment Basic Information
9.5.2 Eli Lilly And Company Premenstrual Syndrome Treatment Product Overview
9.5.3 Eli Lilly And Company Premenstrual Syndrome Treatment Product Market Performance
9.5.4 Eli Lilly And Company Business Overview
9.5.5 Eli Lilly And Company Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Premenstrual Syndrome Treatment Basic Information
9.6.2 GlaxoSmithKline Premenstrual Syndrome Treatment Product Overview
9.6.3 GlaxoSmithKline Premenstrual Syndrome Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Pfizer
9.7.1 Pfizer Premenstrual Syndrome Treatment Basic Information
9.7.2 Pfizer Premenstrual Syndrome Treatment Product Overview
9.7.3 Pfizer Premenstrual Syndrome Treatment Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Shionogi
9.8.1 Shionogi Premenstrual Syndrome Treatment Basic Information
9.8.2 Shionogi Premenstrual Syndrome Treatment Product Overview
9.8.3 Shionogi Premenstrual Syndrome Treatment Product Market Performance
9.8.4 Shionogi Business Overview
9.8.5 Shionogi Recent Developments
9.9 Johnson and Johnson
9.9.1 Johnson and Johnson Premenstrual Syndrome Treatment Basic Information
9.9.2 Johnson and Johnson Premenstrual Syndrome Treatment Product Overview
9.9.3 Johnson and Johnson Premenstrual Syndrome Treatment Product Market Performance
9.9.4 Johnson and Johnson Business Overview
9.9.5 Johnson and Johnson Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG Premenstrual Syndrome Treatment Basic Information
9.10.2 Novartis AG Premenstrual Syndrome Treatment Product Overview
9.10.3 Novartis AG Premenstrual Syndrome Treatment Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 Merck and Co., Inc.
9.11.1 Merck and Co., Inc. Premenstrual Syndrome Treatment Basic Information
9.11.2 Merck and Co., Inc. Premenstrual Syndrome Treatment Product Overview
9.11.3 Merck and Co., Inc. Premenstrual Syndrome Treatment Product Market Performance
9.11.4 Merck and Co., Inc. Business Overview
9.11.5 Merck and Co., Inc. Recent Developments
9.12 Allergan plc
9.12.1 Allergan plc Premenstrual Syndrome Treatment Basic Information
9.12.2 Allergan plc Premenstrual Syndrome Treatment Product Overview
9.12.3 Allergan plc Premenstrual Syndrome Treatment Product Market Performance
9.12.4 Allergan plc Business Overview
9.12.5 Allergan plc Recent Developments
9.13 Mylan N.V.
9.13.1 Mylan N.V. Premenstrual Syndrome Treatment Basic Information
9.13.2 Mylan N.V. Premenstrual Syndrome Treatment Product Overview
9.13.3 Mylan N.V. Premenstrual Syndrome Treatment Product Market Performance
9.13.4 Mylan N.V. Business Overview
9.13.5 Mylan N.V. Recent Developments
10 PREMENSTRUAL SYNDROME TREATMENT MARKET FORECAST BY REGION
10.1 Global Premenstrual Syndrome Treatment Market Size Forecast
10.2 Global Premenstrual Syndrome Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Premenstrual Syndrome Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Premenstrual Syndrome Treatment Market Size Forecast by Region
10.2.4 South America Premenstrual Syndrome Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Premenstrual Syndrome Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Premenstrual Syndrome Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Premenstrual Syndrome Treatment by Type (2025-2030)
11.1.2 Global Premenstrual Syndrome Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Premenstrual Syndrome Treatment by Type (2025-2030)
11.2 Global Premenstrual Syndrome Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Premenstrual Syndrome Treatment Sales (K Units) Forecast by Application
11.2.2 Global Premenstrual Syndrome Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Premenstrual Syndrome Treatment
1.2 Key Market Segments
1.2.1 Premenstrual Syndrome Treatment Segment by Type
1.2.2 Premenstrual Syndrome Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PREMENSTRUAL SYNDROME TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Premenstrual Syndrome Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Premenstrual Syndrome Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PREMENSTRUAL SYNDROME TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Premenstrual Syndrome Treatment Sales by Manufacturers (2019-2024)
3.2 Global Premenstrual Syndrome Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Premenstrual Syndrome Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Premenstrual Syndrome Treatment Sales Sites, Area Served, Product Type
3.6 Premenstrual Syndrome Treatment Market Competitive Situation and Trends
3.6.1 Premenstrual Syndrome Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Premenstrual Syndrome Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PREMENSTRUAL SYNDROME TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Premenstrual Syndrome Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PREMENSTRUAL SYNDROME TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Premenstrual Syndrome Treatment Sales Market Share by Type (2019-2024)
6.3 Global Premenstrual Syndrome Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Premenstrual Syndrome Treatment Price by Type (2019-2024)
7 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Premenstrual Syndrome Treatment Market Sales by Application (2019-2024)
7.3 Global Premenstrual Syndrome Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
8 PREMENSTRUAL SYNDROME TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Premenstrual Syndrome Treatment Sales by Region
8.1.1 Global Premenstrual Syndrome Treatment Sales by Region
8.1.2 Global Premenstrual Syndrome Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Premenstrual Syndrome Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Premenstrual Syndrome Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Premenstrual Syndrome Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Premenstrual Syndrome Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Premenstrual Syndrome Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Premenstrual Syndrome Treatment Basic Information
9.1.2 AbbVie Premenstrual Syndrome Treatment Product Overview
9.1.3 AbbVie Premenstrual Syndrome Treatment Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Premenstrual Syndrome Treatment SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Premenstrual Syndrome Treatment Basic Information
9.2.2 AstraZeneca Premenstrual Syndrome Treatment Product Overview
9.2.3 AstraZeneca Premenstrual Syndrome Treatment Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Premenstrual Syndrome Treatment SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 BASF Corporation
9.3.1 BASF Corporation Premenstrual Syndrome Treatment Basic Information
9.3.2 BASF Corporation Premenstrual Syndrome Treatment Product Overview
9.3.3 BASF Corporation Premenstrual Syndrome Treatment Product Market Performance
9.3.4 BASF Corporation Premenstrual Syndrome Treatment SWOT Analysis
9.3.5 BASF Corporation Business Overview
9.3.6 BASF Corporation Recent Developments
9.4 Bayer
9.4.1 Bayer Premenstrual Syndrome Treatment Basic Information
9.4.2 Bayer Premenstrual Syndrome Treatment Product Overview
9.4.3 Bayer Premenstrual Syndrome Treatment Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Recent Developments
9.5 Eli Lilly And Company
9.5.1 Eli Lilly And Company Premenstrual Syndrome Treatment Basic Information
9.5.2 Eli Lilly And Company Premenstrual Syndrome Treatment Product Overview
9.5.3 Eli Lilly And Company Premenstrual Syndrome Treatment Product Market Performance
9.5.4 Eli Lilly And Company Business Overview
9.5.5 Eli Lilly And Company Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Premenstrual Syndrome Treatment Basic Information
9.6.2 GlaxoSmithKline Premenstrual Syndrome Treatment Product Overview
9.6.3 GlaxoSmithKline Premenstrual Syndrome Treatment Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Pfizer
9.7.1 Pfizer Premenstrual Syndrome Treatment Basic Information
9.7.2 Pfizer Premenstrual Syndrome Treatment Product Overview
9.7.3 Pfizer Premenstrual Syndrome Treatment Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Shionogi
9.8.1 Shionogi Premenstrual Syndrome Treatment Basic Information
9.8.2 Shionogi Premenstrual Syndrome Treatment Product Overview
9.8.3 Shionogi Premenstrual Syndrome Treatment Product Market Performance
9.8.4 Shionogi Business Overview
9.8.5 Shionogi Recent Developments
9.9 Johnson and Johnson
9.9.1 Johnson and Johnson Premenstrual Syndrome Treatment Basic Information
9.9.2 Johnson and Johnson Premenstrual Syndrome Treatment Product Overview
9.9.3 Johnson and Johnson Premenstrual Syndrome Treatment Product Market Performance
9.9.4 Johnson and Johnson Business Overview
9.9.5 Johnson and Johnson Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG Premenstrual Syndrome Treatment Basic Information
9.10.2 Novartis AG Premenstrual Syndrome Treatment Product Overview
9.10.3 Novartis AG Premenstrual Syndrome Treatment Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 Merck and Co., Inc.
9.11.1 Merck and Co., Inc. Premenstrual Syndrome Treatment Basic Information
9.11.2 Merck and Co., Inc. Premenstrual Syndrome Treatment Product Overview
9.11.3 Merck and Co., Inc. Premenstrual Syndrome Treatment Product Market Performance
9.11.4 Merck and Co., Inc. Business Overview
9.11.5 Merck and Co., Inc. Recent Developments
9.12 Allergan plc
9.12.1 Allergan plc Premenstrual Syndrome Treatment Basic Information
9.12.2 Allergan plc Premenstrual Syndrome Treatment Product Overview
9.12.3 Allergan plc Premenstrual Syndrome Treatment Product Market Performance
9.12.4 Allergan plc Business Overview
9.12.5 Allergan plc Recent Developments
9.13 Mylan N.V.
9.13.1 Mylan N.V. Premenstrual Syndrome Treatment Basic Information
9.13.2 Mylan N.V. Premenstrual Syndrome Treatment Product Overview
9.13.3 Mylan N.V. Premenstrual Syndrome Treatment Product Market Performance
9.13.4 Mylan N.V. Business Overview
9.13.5 Mylan N.V. Recent Developments
10 PREMENSTRUAL SYNDROME TREATMENT MARKET FORECAST BY REGION
10.1 Global Premenstrual Syndrome Treatment Market Size Forecast
10.2 Global Premenstrual Syndrome Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Premenstrual Syndrome Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Premenstrual Syndrome Treatment Market Size Forecast by Region
10.2.4 South America Premenstrual Syndrome Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Premenstrual Syndrome Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Premenstrual Syndrome Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Premenstrual Syndrome Treatment by Type (2025-2030)
11.1.2 Global Premenstrual Syndrome Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Premenstrual Syndrome Treatment by Type (2025-2030)
11.2 Global Premenstrual Syndrome Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Premenstrual Syndrome Treatment Sales (K Units) Forecast by Application
11.2.2 Global Premenstrual Syndrome Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Premenstrual Syndrome Treatment Market Size Comparison by Region (M USD)
Table 5. Global Premenstrual Syndrome Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Premenstrual Syndrome Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Premenstrual Syndrome Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Premenstrual Syndrome Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Syndrome Treatment as of 2022)
Table 10. Global Market Premenstrual Syndrome Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Premenstrual Syndrome Treatment Sales Sites and Area Served
Table 12. Manufacturers Premenstrual Syndrome Treatment Product Type
Table 13. Global Premenstrual Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Premenstrual Syndrome Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Premenstrual Syndrome Treatment Market Challenges
Table 22. Global Premenstrual Syndrome Treatment Sales by Type (K Units)
Table 23. Global Premenstrual Syndrome Treatment Market Size by Type (M USD)
Table 24. Global Premenstrual Syndrome Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Premenstrual Syndrome Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Premenstrual Syndrome Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Premenstrual Syndrome Treatment Market Size Share by Type (2019-2024)
Table 28. Global Premenstrual Syndrome Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Premenstrual Syndrome Treatment Sales (K Units) by Application
Table 30. Global Premenstrual Syndrome Treatment Market Size by Application
Table 31. Global Premenstrual Syndrome Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Premenstrual Syndrome Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Premenstrual Syndrome Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Premenstrual Syndrome Treatment Market Share by Application (2019-2024)
Table 35. Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Premenstrual Syndrome Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 43. AbbVie Premenstrual Syndrome Treatment Basic Information
Table 44. AbbVie Premenstrual Syndrome Treatment Product Overview
Table 45. AbbVie Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Premenstrual Syndrome Treatment SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. AstraZeneca Premenstrual Syndrome Treatment Basic Information
Table 50. AstraZeneca Premenstrual Syndrome Treatment Product Overview
Table 51. AstraZeneca Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Premenstrual Syndrome Treatment SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. BASF Corporation Premenstrual Syndrome Treatment Basic Information
Table 56. BASF Corporation Premenstrual Syndrome Treatment Product Overview
Table 57. BASF Corporation Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BASF Corporation Premenstrual Syndrome Treatment SWOT Analysis
Table 59. BASF Corporation Business Overview
Table 60. BASF Corporation Recent Developments
Table 61. Bayer Premenstrual Syndrome Treatment Basic Information
Table 62. Bayer Premenstrual Syndrome Treatment Product Overview
Table 63. Bayer Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bayer Business Overview
Table 65. Bayer Recent Developments
Table 66. Eli Lilly And Company Premenstrual Syndrome Treatment Basic Information
Table 67. Eli Lilly And Company Premenstrual Syndrome Treatment Product Overview
Table 68. Eli Lilly And Company Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Eli Lilly And Company Business Overview
Table 70. Eli Lilly And Company Recent Developments
Table 71. GlaxoSmithKline Premenstrual Syndrome Treatment Basic Information
Table 72. GlaxoSmithKline Premenstrual Syndrome Treatment Product Overview
Table 73. GlaxoSmithKline Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Pfizer Premenstrual Syndrome Treatment Basic Information
Table 77. Pfizer Premenstrual Syndrome Treatment Product Overview
Table 78. Pfizer Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Shionogi Premenstrual Syndrome Treatment Basic Information
Table 82. Shionogi Premenstrual Syndrome Treatment Product Overview
Table 83. Shionogi Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shionogi Business Overview
Table 85. Shionogi Recent Developments
Table 86. Johnson and Johnson Premenstrual Syndrome Treatment Basic Information
Table 87. Johnson and Johnson Premenstrual Syndrome Treatment Product Overview
Table 88. Johnson and Johnson Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Recent Developments
Table 91. Novartis AG Premenstrual Syndrome Treatment Basic Information
Table 92. Novartis AG Premenstrual Syndrome Treatment Product Overview
Table 93. Novartis AG Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Recent Developments
Table 96. Merck and Co., Inc. Premenstrual Syndrome Treatment Basic Information
Table 97. Merck and Co., Inc. Premenstrual Syndrome Treatment Product Overview
Table 98. Merck and Co., Inc. Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck and Co., Inc. Business Overview
Table 100. Merck and Co., Inc. Recent Developments
Table 101. Allergan plc Premenstrual Syndrome Treatment Basic Information
Table 102. Allergan plc Premenstrual Syndrome Treatment Product Overview
Table 103. Allergan plc Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Allergan plc Business Overview
Table 105. Allergan plc Recent Developments
Table 106. Mylan N.V. Premenstrual Syndrome Treatment Basic Information
Table 107. Mylan N.V. Premenstrual Syndrome Treatment Product Overview
Table 108. Mylan N.V. Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Mylan N.V. Business Overview
Table 110. Mylan N.V. Recent Developments
Table 111. Global Premenstrual Syndrome Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Premenstrual Syndrome Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Premenstrual Syndrome Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Premenstrual Syndrome Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Premenstrual Syndrome Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Premenstrual Syndrome Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Premenstrual Syndrome Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Premenstrual Syndrome Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Premenstrual Syndrome Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Premenstrual Syndrome Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Premenstrual Syndrome Treatment Market Size Comparison by Region (M USD)
Table 5. Global Premenstrual Syndrome Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Premenstrual Syndrome Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Premenstrual Syndrome Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Premenstrual Syndrome Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Syndrome Treatment as of 2022)
Table 10. Global Market Premenstrual Syndrome Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Premenstrual Syndrome Treatment Sales Sites and Area Served
Table 12. Manufacturers Premenstrual Syndrome Treatment Product Type
Table 13. Global Premenstrual Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Premenstrual Syndrome Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Premenstrual Syndrome Treatment Market Challenges
Table 22. Global Premenstrual Syndrome Treatment Sales by Type (K Units)
Table 23. Global Premenstrual Syndrome Treatment Market Size by Type (M USD)
Table 24. Global Premenstrual Syndrome Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Premenstrual Syndrome Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Premenstrual Syndrome Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Premenstrual Syndrome Treatment Market Size Share by Type (2019-2024)
Table 28. Global Premenstrual Syndrome Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Premenstrual Syndrome Treatment Sales (K Units) by Application
Table 30. Global Premenstrual Syndrome Treatment Market Size by Application
Table 31. Global Premenstrual Syndrome Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Premenstrual Syndrome Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Premenstrual Syndrome Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Premenstrual Syndrome Treatment Market Share by Application (2019-2024)
Table 35. Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Premenstrual Syndrome Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Premenstrual Syndrome Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Premenstrual Syndrome Treatment Sales by Region (2019-2024) & (K Units)
Table 43. AbbVie Premenstrual Syndrome Treatment Basic Information
Table 44. AbbVie Premenstrual Syndrome Treatment Product Overview
Table 45. AbbVie Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Premenstrual Syndrome Treatment SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. AstraZeneca Premenstrual Syndrome Treatment Basic Information
Table 50. AstraZeneca Premenstrual Syndrome Treatment Product Overview
Table 51. AstraZeneca Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Premenstrual Syndrome Treatment SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. BASF Corporation Premenstrual Syndrome Treatment Basic Information
Table 56. BASF Corporation Premenstrual Syndrome Treatment Product Overview
Table 57. BASF Corporation Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BASF Corporation Premenstrual Syndrome Treatment SWOT Analysis
Table 59. BASF Corporation Business Overview
Table 60. BASF Corporation Recent Developments
Table 61. Bayer Premenstrual Syndrome Treatment Basic Information
Table 62. Bayer Premenstrual Syndrome Treatment Product Overview
Table 63. Bayer Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bayer Business Overview
Table 65. Bayer Recent Developments
Table 66. Eli Lilly And Company Premenstrual Syndrome Treatment Basic Information
Table 67. Eli Lilly And Company Premenstrual Syndrome Treatment Product Overview
Table 68. Eli Lilly And Company Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Eli Lilly And Company Business Overview
Table 70. Eli Lilly And Company Recent Developments
Table 71. GlaxoSmithKline Premenstrual Syndrome Treatment Basic Information
Table 72. GlaxoSmithKline Premenstrual Syndrome Treatment Product Overview
Table 73. GlaxoSmithKline Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Pfizer Premenstrual Syndrome Treatment Basic Information
Table 77. Pfizer Premenstrual Syndrome Treatment Product Overview
Table 78. Pfizer Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Shionogi Premenstrual Syndrome Treatment Basic Information
Table 82. Shionogi Premenstrual Syndrome Treatment Product Overview
Table 83. Shionogi Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shionogi Business Overview
Table 85. Shionogi Recent Developments
Table 86. Johnson and Johnson Premenstrual Syndrome Treatment Basic Information
Table 87. Johnson and Johnson Premenstrual Syndrome Treatment Product Overview
Table 88. Johnson and Johnson Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Recent Developments
Table 91. Novartis AG Premenstrual Syndrome Treatment Basic Information
Table 92. Novartis AG Premenstrual Syndrome Treatment Product Overview
Table 93. Novartis AG Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Recent Developments
Table 96. Merck and Co., Inc. Premenstrual Syndrome Treatment Basic Information
Table 97. Merck and Co., Inc. Premenstrual Syndrome Treatment Product Overview
Table 98. Merck and Co., Inc. Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck and Co., Inc. Business Overview
Table 100. Merck and Co., Inc. Recent Developments
Table 101. Allergan plc Premenstrual Syndrome Treatment Basic Information
Table 102. Allergan plc Premenstrual Syndrome Treatment Product Overview
Table 103. Allergan plc Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Allergan plc Business Overview
Table 105. Allergan plc Recent Developments
Table 106. Mylan N.V. Premenstrual Syndrome Treatment Basic Information
Table 107. Mylan N.V. Premenstrual Syndrome Treatment Product Overview
Table 108. Mylan N.V. Premenstrual Syndrome Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Mylan N.V. Business Overview
Table 110. Mylan N.V. Recent Developments
Table 111. Global Premenstrual Syndrome Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Premenstrual Syndrome Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Premenstrual Syndrome Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Premenstrual Syndrome Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Premenstrual Syndrome Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Premenstrual Syndrome Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Premenstrual Syndrome Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Premenstrual Syndrome Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Premenstrual Syndrome Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Premenstrual Syndrome Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Premenstrual Syndrome Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Premenstrual Syndrome Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Premenstrual Syndrome Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Premenstrual Syndrome Treatment Market Size (M USD), 2019-2030
Figure 5. Global Premenstrual Syndrome Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Premenstrual Syndrome Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Premenstrual Syndrome Treatment Market Size by Country (M USD)
Figure 11. Premenstrual Syndrome Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Premenstrual Syndrome Treatment Revenue Share by Manufacturers in 2023
Figure 13. Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Premenstrual Syndrome Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Premenstrual Syndrome Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Premenstrual Syndrome Treatment Market Share by Type
Figure 18. Sales Market Share of Premenstrual Syndrome Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Premenstrual Syndrome Treatment by Type in 2023
Figure 20. Market Size Share of Premenstrual Syndrome Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Premenstrual Syndrome Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Premenstrual Syndrome Treatment Market Share by Application
Figure 24. Global Premenstrual Syndrome Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Premenstrual Syndrome Treatment Sales Market Share by Application in 2023
Figure 26. Global Premenstrual Syndrome Treatment Market Share by Application (2019-2024)
Figure 27. Global Premenstrual Syndrome Treatment Market Share by Application in 2023
Figure 28. Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Premenstrual Syndrome Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Premenstrual Syndrome Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Premenstrual Syndrome Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 37. Germany Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Premenstrual Syndrome Treatment Sales Market Share by Region in 2023
Figure 44. China Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 50. South America Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Premenstrual Syndrome Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Premenstrual Syndrome Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Premenstrual Syndrome Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Premenstrual Syndrome Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Premenstrual Syndrome Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Premenstrual Syndrome Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Premenstrual Syndrome Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Premenstrual Syndrome Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Premenstrual Syndrome Treatment Market Size (M USD), 2019-2030
Figure 5. Global Premenstrual Syndrome Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Premenstrual Syndrome Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Premenstrual Syndrome Treatment Market Size by Country (M USD)
Figure 11. Premenstrual Syndrome Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Premenstrual Syndrome Treatment Revenue Share by Manufacturers in 2023
Figure 13. Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Premenstrual Syndrome Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Premenstrual Syndrome Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Premenstrual Syndrome Treatment Market Share by Type
Figure 18. Sales Market Share of Premenstrual Syndrome Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Premenstrual Syndrome Treatment by Type in 2023
Figure 20. Market Size Share of Premenstrual Syndrome Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Premenstrual Syndrome Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Premenstrual Syndrome Treatment Market Share by Application
Figure 24. Global Premenstrual Syndrome Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Premenstrual Syndrome Treatment Sales Market Share by Application in 2023
Figure 26. Global Premenstrual Syndrome Treatment Market Share by Application (2019-2024)
Figure 27. Global Premenstrual Syndrome Treatment Market Share by Application in 2023
Figure 28. Global Premenstrual Syndrome Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Premenstrual Syndrome Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Premenstrual Syndrome Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Premenstrual Syndrome Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 37. Germany Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Premenstrual Syndrome Treatment Sales Market Share by Region in 2023
Figure 44. China Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 50. South America Premenstrual Syndrome Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Premenstrual Syndrome Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Premenstrual Syndrome Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Premenstrual Syndrome Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Premenstrual Syndrome Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Premenstrual Syndrome Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Premenstrual Syndrome Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Premenstrual Syndrome Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Premenstrual Syndrome Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Premenstrual Syndrome Treatment Market Share Forecast by Application (2025-2030)
